Collegium Pharmaceutical, Inc. Common Stock COLL
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERICi
Market dataready · fetched 2026-11-11T14:50:06.931Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:49:28.408553223Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T14:40:39.133902+00:00
Collegium Pharmaceutical, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | 34.90 | 146.1% | 50.7% | |||
| 35Δ | 33.58 | 139.7% | 47.0% | |||
| 40Δ | 32.27 | 133.4% | 43.2% | |||
| 45Δ | 30.95 | 127.1% | 39.4% | |||
| 50Δ | 29.64 | 120.8% | 35.6% | 25.04 | 71.6% | 7.6% |
| 55Δ | 28.32 | 114.5% | 31.8% | 25.69 | 69.0% | 6.6% |
| 60Δ | 27.01 | 108.2% | 28.0% | 26.34 | 66.3% | 5.7% |
| 65Δ | 25.69 | 101.9% | 24.2% | 27.00 | 63.7% | 4.7% |
| 70Δ | 24.38 | 95.5% | 20.4% | 27.65 | 61.1% | 3.8% |
| 75Δ | 23.06 | 89.2% | 16.6% | 28.30 | 58.4% | 2.9% |
| 80Δ | 21.75 | 82.9% | 12.9% | 28.95 | 55.8% | 1.9% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 34.90
- IV
- 146.1%
- B/E move
- 50.7%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 33.58
- IV
- 139.7%
- B/E move
- 47.0%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 32.27
- IV
- 133.4%
- B/E move
- 43.2%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 30.95
- IV
- 127.1%
- B/E move
- 39.4%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 29.64
- IV
- 120.8%
- B/E move
- 35.6%
- Pseudo strike
- 25.04
- IV
- 71.6%
- B/E move
- 7.6%
55Δ
- Pseudo strike
- 28.32
- IV
- 114.5%
- B/E move
- 31.8%
- Pseudo strike
- 25.69
- IV
- 69.0%
- B/E move
- 6.6%
60Δ
- Pseudo strike
- 27.01
- IV
- 108.2%
- B/E move
- 28.0%
- Pseudo strike
- 26.34
- IV
- 66.3%
- B/E move
- 5.7%
65Δ
- Pseudo strike
- 25.69
- IV
- 101.9%
- B/E move
- 24.2%
- Pseudo strike
- 27.00
- IV
- 63.7%
- B/E move
- 4.7%
70Δ
- Pseudo strike
- 24.38
- IV
- 95.5%
- B/E move
- 20.4%
- Pseudo strike
- 27.65
- IV
- 61.1%
- B/E move
- 3.8%
75Δ
- Pseudo strike
- 23.06
- IV
- 89.2%
- B/E move
- 16.6%
- Pseudo strike
- 28.30
- IV
- 58.4%
- B/E move
- 2.9%
80Δ
- Pseudo strike
- 21.75
- IV
- 82.9%
- B/E move
- 12.9%
- Pseudo strike
- 28.95
- IV
- 55.8%
- B/E move
- 1.9%
Options history
Table
| Date | IV (%) |
|---|---|
| 73.45% | |
| 70.13% | |
| 73.14% | |
| 75.04% | |
| 79.01% | |
| 83.12% | |
| 80.70% | |
| 74.72% | |
| 74.01% | |
| 72.43% |
Drug Manufacturers - Specialty & Generic
CPIX
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and marketing of prescription products for hospital acute care,…
More →CRDL
Cardiol Therapeutics Inc., a clinical-phase biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular…
More →CRON
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
More →DERM
Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
More →EBS
Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations that address…
More →ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals. The company is headquartered in…
More →